Download PDF
Thromb Haemost 1997; 78(01): 759-764
DOI: 10.1055/s-0038-1657625
Tissue factor
Schattauer GmbH Stuttgart

Tissue Factor in Health and Disease

Nicola Semeraro
Department of Biomedical Sciences and Human Oncology, Section of General Pathology, University of Bari, Italy
,
Mario Colucci
Department of Biomedical Sciences and Human Oncology, Section of General Pathology, University of Bari, Italy
› Author Affiliations
Further Information

Publication History

Publication Date:
12 July 2018 (online)

  PDF Download  Permissions and Reprints
 

  • References

  • 1 Camerer E, Kolsto PrydzH. Cell biology of tissue factor, the principal initiator of blood coagulation. Thromb Res 1996; 81: 01-41
    CrossrefPubMedGoogle Scholar
  • 2 Mueller BM, Reisfeld RA, Edgington TS, Ruf W. Expression of tissue factor by melanoma cells promotes efficient hematogenous metastasis. Proc Natl Acad Sci USA 1992; 89: 11832-11836
    CrossrefPubMedGoogle Scholar
  • 3 Zhang Y, Deng Y, Luther T, Muller M, Ziegler R, Waldherr R, Stern DM, Nawroth PR. Tissue factor controls the balance of angiogenic and antiangiogenic properties of tumor cells in mice. J Clin Invest 1994; 94: 1320-1327
    CrossrefPubMedGoogle Scholar
  • 4 Nemerson Y. The tissue factor pathway of blood coagulation. In: Hemostasis and thrombosis. Basic principles and clinical practice. Colman RW, Hirsh J, Marder VJ, Salzman EW. eds. J. B. Lippincott Company; Philadelphia, PA: 1994. pp 81-93
    Google Scholar
  • 5 Mackman N. Regulation of the tissue factor gene. FASEB J 1995; 9: 883-889
    CrossrefPubMedGoogle Scholar
  • 6 Rapaport SI, Rao LVM. The tissue factor pathway: how it has become a “prima ballerina”. Thromb Haemost 1995; 74: 07-17
    PubMedGoogle Scholar
  • 7 Ruf W, Edgington TS. Structural biology of tissue factor, the initiator of thrombogenesis in vivo. FASEB J 1994; 8: 385-390
    CrossrefPubMedGoogle Scholar
  • 8 Drake TA, Morissey JW, Edgington TS. Selective cellular expression of tissue factor in human tissues. Am J Pathol 1989; 134: 1087-1097
    PubMedGoogle Scholar
  • 9 Fleck RA, Rao LVM, Rapaport SI, Varki N. Localization of human tissue factor antigen by immunostaining with monospecific, polyclonal anti-human tissue factor antibody. Thromb Res 1990; 57: 765-781
    CrossrefPubMedGoogle Scholar
  • 10 Wilcox JN, Smith KM, Schwartz SM, Gordon D. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci USA 1989; 86: 2839-2843
    CrossrefPubMedGoogle Scholar
  • 11 Toomey JR, Kratzer KE, Lasky NM, Stanton JJ, Broze Jr GJ. Targeted disruption of the murine tissue factor gene results in embryonic lethality. Blood 1996; 88: 1583-1587
    PubMedGoogle Scholar
  • 12 Carmeliet P, Mackman N, Moons L, Luther T, Gressens P, Van Vlaenderen I, Demunck H, Kasper M, Breier G, Evrard P, Muller M, Risau W, Edgington T, Collen D. Role of tissue factor in embryonic blood vessel development. Nature 1996; 383: 73-75
    CrossrefPubMedGoogle Scholar
  • 13 Bugge TH, Xiao Q, Kombrinck KW, Holmback K, Danton MJS, Colbert MC, Witte DP, Fujikawa K, Davie EN, Degan JL. Fatal embryonic bleeding events in mice lacking tissue factor, the cell-associated initiator of blood coagulation. Proc Natl Acad Sci USA 1996; 93: 6258-6261
    CrossrefPubMedGoogle Scholar
  • 14 Bauer KA, Kass BL, ten Cate H, Hawiger J, Rosenberg RD. Factor IX is activated by the tissue factor mechanism. Blood 1990; 76: 731-736
    PubMedGoogle Scholar
  • 15 Bauer KA, Kass BL, ten Cate H, Bednarek MA, Hawiger J, Rosenberg RD. Detection of factor X activation in humans. Blood 1989; 74: 2007-2015
    PubMedGoogle Scholar
  • 16 Francis JL, Carvalho M, Francis DA. The clinical value of tissue factor assays. Blood Coagul Fibrinol 1995; 6 (Suppl. 01) S37-S44
    CrossrefPubMedGoogle Scholar
  • 17 Levi M, ten Cate H, van der Poll T, van Deventer SJH. Pathogenesis of disseminated intravascular coagulation in sepsis. JAMA 1993; 270: 975-979
    CrossrefPubMedGoogle Scholar
  • 18 Semeraro N, Colucci M. Changes in the coagulation-fibrinolysis balance of endothelial cells and mononuclear phagocytes: role in disseminated intravascular coagulation associated with infectious diseases. Int J Clin Lab Res 1992; 21: 214-220
    CrossrefPubMedGoogle Scholar
  • 19 Creasey AA, Chang ACK, Feigen L, Wun T-C, Taylor FB, Hinshaw LB. Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock. J Clin Invest 1993; 91: 2850-2860
    CrossrefPubMedGoogle Scholar
  • 20 Semeraro N, Colucci M, Mussoni L, Donati MB. Rat blood leukocytes, unlike rabbit leukocytes, do not generate procoagulant activity on exposure to endotoxin. Br J Exp Path 1981; 62: 638-642
    PubMedGoogle Scholar
  • 21 Rothberger H, Dove FB, Lee TK, McGee MP, Kardon B. Procoagulant activity of lymphocyte-macrophage populations in rabbits: selective increases in marrow, blood and spleen cells during Shwartzman reactions. Blood 1983; 61: 712-717
    PubMedGoogle Scholar
  • 22 Montemurro P, Lattanzio A, Chetta G, Lupo L, Caputi-Iambrenghi L, Rubino M, Giordano D, Semeraro N. Increased in vitro and in vivo generation of procoagulant activity (tissue factor) by mononuclear phagocytes after intralipid infusion in rabbits. Blood 1985; 65: 1391-1395
    PubMedGoogle Scholar
  • 23 Semeraro N, Triggiani R, Montemurro P, Cavallo LG, Colucci M. Enhanced endothelial tissue factor but normal thrombomodulin in endotoxin-treated rabbits. Thromb Res 1993; 71: 479-486
    CrossrefPubMedGoogle Scholar
  • 24 Mackman N, Sawdey MS, Keeton MR, Loskutoff DJ. Murine tissue factor gene expression in vivo. Tissue and cell specificity and regulation by lipopolysaccharide. Am J Pathol 1993; 143: 76-84
    PubMedGoogle Scholar
  • 25 Drake TA, Cheng J, Chang A, Taylor Jr FB. Expression of tissue factor, thrombomodulin, and E-selectin in baboons with lethal Escherichia coli sepsis. Am J Pathol 1993; 142: 1458-1470
    PubMedGoogle Scholar
  • 26 Muller-Berghaus G. The role of platelets, leukocytes and complement in the activation of intravascular coagulation by endotoxin. In: Platelets: a multidisciplinary approach. de Gaetano G, Garattini S. eds. Raven Press; New York: 1978. pp 303-320
    Google Scholar
  • 27 Semeraro N, Montemurro P, Piccoli C, Muolo V, Colucci M, Giuliani G, Fumarola D, Pece Salvatore, Moran AP. Effect of Helicobacter pylori lipopolysaccharide (LPS) and LPS derivatives on the production of tissue factor and plasminogen activator inhibitor type 2 by human blood mononuclear cells. J Infect Dis 1996; 174: 1255-1260
    CrossrefPubMedGoogle Scholar
  • 28 Osterud B, Flaegstad T. Increased thromboplastin activity in monocytes of patients with meningococcal infections: related to unfavourable prognosis. Thromb Haemost 1983; 49: 5-7
    Article in Thieme ConnectPubMedGoogle Scholar
  • 29 Almdahl SM, Brox JH, Osterud B. Mononuclear phagocyte thromboplastin and endotoxin in patients with secondary peritonitis. Scand J Gastroenterol 1987; 22: 914-918
    CrossrefPubMedGoogle Scholar
  • 30 Semeraro N, Montemurro P, Chetta G, Altomare DF, Giordano D, Colucci M. Increased procoagulant activity of peripheral blood monocytes in human and experimental obstructive jaundice. Gastroenterology 1989; 96: 892-898
    CrossrefPubMedGoogle Scholar
  • 31 Idell S, James KK, Levin EG, Schwartz BS, Manchanda N, Maunder RJ, Martin TR, McLarty J, Fair DS. Local abnormalities in coagulation and fibrinolytic pathways predispose to alveolar fibrin deposition in adult respiratory distress syndrome. J Clin Invest 1989; 84: 695-705
    CrossrefPubMedGoogle Scholar
  • 32 Haj MA, Neilly ij, Robbie LA, Adey GD, Bennett B. Influence of white blood cells on the fibrinolytic response to sepsis: studies of septic patients with or without severe leucopenia. Br J Haematol 1995; 90: 541-547
    CrossrefPubMedGoogle Scholar
  • 33 Clozel M, Kuhn H, Baumgartner HR. Procoagulant activity of endotoxin-treated human endothelial cells exposed to native human flowing blood. Blood 1989; 73: 729-733
    PubMedGoogle Scholar
  • 34 Barstad RM, Hamers MJAG, Kierulf P, Westvik AB, Sakariassen KS. Procoagulant human monocytes mediate tissue factor/factor VIIa-dependent platelet-thrombus formation when exposed to flowing nonanticoagulated human blood. Arterioscler Thromb Vasc Biol 1995; 15: 11-16
    CrossrefPubMedGoogle Scholar
  • 35 Kato K, Ali Elsayed Y, Namoto M, Nakagawa K, Sueishi K. Enhanced expression of tissue factor activity in the atherosclerotic aortas of cholesterol-fed rabbits. Thromb Res 1996; 82: 335-347
    CrossrefPubMedGoogle Scholar
  • 36 Semeraro N, Montemurro P, Giordano D, Pasquetto N, Curci E, Triggiani R, Colucci M. Increased macrophage procoagulant activity but normal endothelial thrombomodulin in rabbits fed an atherogenic diet. Haemostasis 1990; 20: 54-61
    PubMedGoogle Scholar
  • 37 Marmur JD, Rossikhina M, Guha A, Fyfe B, Friedrich V, Mendlowitz M, Nemerson Y, Taubman MB. Tissue factor is rapidly induced in arterial smooth muscle after balloon injury. J Clin Invest 1993; 91: 2253-2259
    CrossrefPubMedGoogle Scholar
  • 38 Speidel CM, Eisenberg PR, Ruf W, Edgington TS, Abendschein DR. Tissue factor mediates prolonged procoagulant activity on the luminal surface of balloon-injured aortas in rabbits. Circulation 1995; 92: 3323-3330
    CrossrefPubMedGoogle Scholar
  • 39 Golino P, Ragni M, Cirillo P, Avvedimento VE, Feliciello A, Esposito N, Scognamiglio A, Trimarco B, Iaccarino G, Condorelli M, Chiariello M, Ambrosio G. Effects of tissue factor induced by oxygen free radicals on coronary flow during reperfusion. Nature Med 1996; 2: 35-40
    CrossrefPubMedGoogle Scholar
  • 40 Tipping PG, Malliaros J, Holdsworth SR. Procoagulant activity expression by macrophages from atheromatous plaques. Atherosclerosis 1989; 79: 237-243
    CrossrefPubMedGoogle Scholar
  • 41 Annex BH, Denning SM, Channon KM, Sketch Jr MH, Stack RS, Morissey JH, Peters KG. Differential expression of tissue factor protein in directional atherectomy specimens from patients with stable and unstable coronary syndromes. Circulation 1995; 91: 619-622
    CrossrefPubMedGoogle Scholar
  • 42 Marmur JD, Thiruvikraman SV, Fyfe BS, Guha A, Sharma SK, Ambrose JA, Fallon JT, Nemerson Y, Taubman MB. Identification of active tissue factor in human coronary atheroma. Circulation 1996; 94: 1226-1232
    CrossrefPubMedGoogle Scholar
  • 43 Thiruvikraman SV, Guha A, Roboz J, Taubman MB, Nemerson Y, Fallon JT. In situ localization of tissue factor in human atherosclerotic plaques by binding of digoxigenin-labeled factors vIIa and X. Lab Invest 1996; 75: 451-461
    PubMedGoogle Scholar
  • 44 Moreno PR, Bernardi VH, Lopez-Cuéllar J, Murcia AM, Palacios IF, Gold HK, Mehran R, Sharma SK, Nemerson Y, Fuster V, Fallon JT. Macrophages, smooth muscle cells, and tissue factor in unstable angina - Implications for cell-mediated thrombogenicity in acute coronary syndromes. Circulation 1996; 94: 3090-3097
    CrossrefPubMedGoogle Scholar
  • 45 Neri SerneriGG, Abbate R, Gori AM, Attanasio M, Martini F, Giusti B, Dabizzi P, Poggesi L, Modesti PA, Trotta F, Rostagno C, Boddi M, Gensini GF. Transient intermittent lymphocyte activation is responsible for the instability of angina. Circulation 1992; 86: 790-797
    CrossrefPubMedGoogle Scholar
  • 46 Jude B, Agaou B, McFadden EP, Susen S, Bauters C, Lepelley P, Vanhaesbroucke C, Devos P, Cosson A, Asseman P. Evidence for time-dependent activation of monocytes in the systemic circulation in unstable angina but not in acute myocardial infarction or in stable angina. Circulation 1994; 90: 1662-1668
    CrossrefPubMedGoogle Scholar
  • 47 Leatham EW, Bath PMW, Tooze JA, Camm AJ. Increased monocyte tissue factor expression in coronary disease. Br Heart J 1995; 73: 10-13
    PubMedGoogle Scholar
  • 48 Thomas D. Venous thrombogenesis. Br Med Bull 1994; 50: 803-812
    CrossrefPubMedGoogle Scholar
  • 49 Scagnol I, Fumagalli G, Colucci M, Semeraro N. Induction of venous thrombosis by monocyte procoagulant activity in rabbits. Thromb Haemost 1991; 65: 1086
    PubMedGoogle Scholar
  • 50 Bemat A, Sainte-Marie M, Roque C, Ingelaere V, Maffrand JP, Herbert JM. Low doses of endotoxin potentiate venous thrombosis in the rabbit. Haemostasis 1994; 24: 209-218
    PubMedGoogle Scholar
  • 51 Miller CL, Graziano C, Lim RC, Chin M. Generation of tissue factor by patient monocytes: correlation to thromboembolic complications. Thromb Haemost 1981; 42: 489-495
    Article in Thieme ConnectPubMedGoogle Scholar
  • 52 Blakowski SA, Zackarski LR, Beck JR. Postoperative elevation of human peripheral blood monocyte tissue factor coagulant activity. J Lab Clin Med 1986; 108: 117-120
    PubMedGoogle Scholar
  • 53 Ollivier V, Sheibani A, Chollet-Martin S, Vie P, Benacerraf R, Duparc J, de Prost D. Monocyte procoagulant activity and membrane-associated D Dimer after knee replacement surgery. Thromb Res 1989; 55: 179-185
    CrossrefPubMedGoogle Scholar
  • 54 Dvorak HF. Abnormalities of hemostasis in malignant disease. In: Hemostasis and thrombosis. Basic principles and clinical practice. Colman RW, Hirsh J, Marder VJ, Salzman EW. eds. J. B. Lippincott Company; Philadelphia, PA: 1994. pp 1238-1254
    Google Scholar
  • 55 Donati MB, Semeraro N. Cancer cell procoagulants and their pharmacological modulation. Haemostasis 1984; 14: 422-429
    PubMedGoogle Scholar
  • 56 Rickies FR, Edwards RL. Leukocytes and tumor cells in thrombosis. In: Hemostasis and thrombosis. Basic principles and clinical practice. Colman RW, Hirsh J, Marder VJ, Salzman EW. eds. J. B. Lippincott Company; Philadelphia, PA: 1994. pp 1164-1179
    Google Scholar
  • 57 Rambaldi A, Alessio G, Casali B, Passerini CG, Donati MB, Mantovani A, Semeraro N. Induction of monocyte-macrophage procoagulant activity by transformed cell lines. J Immunol 1986; 136: 3848-3855
    PubMedGoogle Scholar
  • 58 Tanaka M, Yamanishi H. The expression of tissue factor antigen and activity on the surface of leukemic cells. Leuk Res 1993; 17: 103-111
    CrossrefPubMedGoogle Scholar
  • 59 Conese M, Montemurro P, Fumarulo R, Giordano D, Riccardi S, Colucci M, Semeraro N. Inhibitory effect of retinoids on the generation of procoagulant activity by blood mononuclear cells. Thromb Haemost 1991; 66: 662-665
    Article in Thieme ConnectPubMedGoogle Scholar
  • 60 De Stefano V, Teofili L, Sica S, Mastrangelo S, Di Mario A, Rutella S, Salutari P, Rumi C, d’Onofrio G, Leone G. Effect of all-trans retinoic acid on procoagulant and fibrinolytic activities of cultured blast cells from patients with acute promyelocytic leukemia. Blood 1995; 86: 3535-3541
    PubMedGoogle Scholar
  • 61 Falanga A, Iacoviello L, Evangelista V, Belotti D, Consonni R, D’Orazio A, Robba L, Donati MB, Barbui T. Loss of blast cell procoagulant activity and improvement of hemostatic variables in patients with acute promyelocytic leukemia administered all-trans-retinoic acid. Blood 1995; 86: 1072-1081
    PubMedGoogle Scholar
  • 62 Callander NS, Varki N, Rao LVM. Immunohistochemical identification of tissue factor in solid tumors. Cancer 1992; 70: 1194-1201
    CrossrefPubMedGoogle Scholar
  • 63 Costantini V, Zackarski LR. Fibrin and cancer. Thromb Haemost 1993; 69: 406-414
    Article in Thieme ConnectPubMedGoogle Scholar
  • 64 Hamada K, Kuratsu J, Saitoh TakeshimaH, Ushio Y. Expression of tissue factor correlates with grade of malignancy in human glioma. Cancer 1996; 77: 1877-1883
    CrossrefPubMedGoogle Scholar
  • 65 Chen Z, Sager R. Differential expression of human tissue factor in normal mammary epithelial cells and in carcinomas. Mol Med 1995; 1: 153-160
    PubMedGoogle Scholar
  • 66 Semeraro N. Different expression of procoagulant activity in macrophages associated with experimental and human tumors. Haemostasis 1988; 18: 47-54
    PubMedGoogle Scholar
  • 67 Semeraro N, Montemurro P, Conese M, Giordano D, Stella M, Restaino A, Cagnazzo G, Colucci M. Procoagulant activity of mononuclear phagocytes from different anatomical sites in patients with gynecological malignancies. Int J Cancer 45: 251-254 1990;
    CrossrefPubMedGoogle Scholar
  • 68 Mantovani A, Semeraro N. Tumor-associated macrophages and their modulatory role in tumor progression. In: Tumor matrix biology. Adany R. ed. CRC Press; Boca Raton, FI: 1995. pp 173-187
    Google Scholar
  • 69 Ruco LP, Pittiglio M, Dejana E, Baroni CD. Vascular activation in the histopathogenesis of Hodgkin’s disease: potential role of endothelial tissue factor in intravascular thrombosis and necrosis. J Pathol 1993; 171: 131-136
    CrossrefPubMedGoogle Scholar
  • 70 Contrino J, Hair G, Kreutzer DL, Rickies FR. In situ detection of tissue factor in vascular endothelial cells: Correlation with the malignant phenotype of human breast cancer. Nature Med 1996; 2: 209-215
    CrossrefPubMedGoogle Scholar
  • 71 Vrana JA, Stang MT, Grande JP, Getz MJ. Expression of tissue factor in tumor stroma correlates with progression to invasive human breast cancer: Paracrine regulation by carcinoma cellderived members of the transforming growth factor beta family. Cancer Res 1996; 56: 5063-5070
    PubMedGoogle Scholar
  • 72 Kakkar AK, Lemoine NR, Scully MF, Tebbutt S, Williamson RCN. Tissue factor expression correlates with histological grade in human pancreatic cancer. Br J Surg 1995; 82: 1101-1104
    CrossrefPubMedGoogle Scholar
  • 73 Bromberg ME, Konigsberg WH, Madison JF, Pawashe A, Garen A. Tissue factor promotes melanoma metastasis by a pathway independent of blood coagulation. Proc Natl Acad Sci USA 1995; 92: 8205-8209
    CrossrefPubMedGoogle Scholar
  • 74 Morgan D, Edwards RL, Rickies FR. Monocyte procoagulant activity as a peripheral marker of clottin activation in cancer patients. Haemostasis 1988; 18: 55-65
    PubMedGoogle Scholar
  • 75 Semeraro N, Montemurro P, Giordano P, Santoro N, De Mattia D, Colucci M. Increased mononuclear cell tissue factor and type 2 plasminogen activator inhibitor and reduced plasma fi#brinolytic capacity in children with lymphoma. Thromb Haemost 1994; 72: 54-57
    PubMedGoogle Scholar
  • 76 Montemurro P, Conese M, Altomare DF, Memeo V, Colucci M, Semeraro N. Blood and tissue fibrinolytic profiles in patients with colorectal carcinoma. Int J Clin Lab Res 1995; 25: 195-200
    CrossrefPubMedGoogle Scholar
  • 77 Kakkar AK, DeRuvo N, Chinswangwatanakul V, Tebbutt S, Williamson RCN. Extrinsic-pathway activation in cancer with high factor VIIa and tissue factor. Lancet 1995; 346: 1004-1005
    CrossrefPubMedGoogle Scholar